Elanco Animal Health announces Lilly’s agreement to acquire ChemGen Corp.
24 January 2012 | By Eli Lilly and Company
Elanco, announced that Lilly has signed an agreement to acquire ChemGen Corp., a privately held bioscience company...
List view / Grid view
24 January 2012 | By Eli Lilly and Company
Elanco, announced that Lilly has signed an agreement to acquire ChemGen Corp., a privately held bioscience company...
24 January 2012 | By Novo Nordisk
Novo Nordisk announced that the company will establish a type 1 diabetes R&D center in Seattle, US...
24 January 2012 | By Bristol-Myers Squibb Company
Bristol-Myers Squibb Company announced that its Board of Directors has elected Gerald L. Storch to the Board...
23 January 2012 | By Roche
Establishment of a program to improve basic cancer care in Ethiopia...
20 January 2012 | By Novartis
If approved, Signifor would be the first approved medication targeting Cushing's disease...
20 January 2012 | By Biogen Idec and Elan Corporation, plc
The U.S. FDA has approved a product label change for TYSABRI...
20 January 2012 | By Novartis
Update of the Glivec® (imatinib)* label...
19 January 2012 | By Merck
Merck announced that it has entered into an agreement to resolve all claims related to Vioxx® in Canada...
19 January 2012 | By Bristol-Myers Squibb Company
Donation of $6.9 million in 2011 to support the HealthWell Foundation...
19 January 2012 | By B&W Tek
B&W Tek, Inc., is proud to introduce BWSpec™ 4.00...
19 January 2012 | By Acquire Media
Patheon and PROCAPS S.A. are pleased to announce an agreement to provide the pharmaceutical industry a new world-class line of prescription pharmaceutical soft-gel product development and manufacturing services...
19 January 2012 | By Novartis
Sandoz announced that it has initiated two milestone Phase III clinical trials...
19 January 2012 | By AstraZeneca
The FDA has issued a complete response letter regarding dapagliflozin...
18 January 2012 | By Abbott
The U.S. FDA will begin implementing Abbott’s STARLIMS® software-based laboratory information management system...
18 January 2012 | By Gilead Sciences Inc
Gilead Sciences, Inc. announced that the U.S. FDA has approved Viread®...